Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons
Open Access
- 3 February 2014
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 211 (2), 245-262
- https://doi.org/10.1084/jem.20131043
Abstract
Type I interferons (IFN-1s) are antiviral cytokines that suppress blood production while paradoxically inducing hematopoietic stem cell (HSC) proliferation. Here, we clarify the relationship between the proliferative and suppressive effects of IFN-1s on HSC function during acute and chronic IFN-1 exposure. We show that IFN-1–driven HSC proliferation is a transient event resulting from a brief relaxation of quiescence-enforcing mechanisms in response to acute IFN-1 exposure, which occurs exclusively in vivo. We find that this proliferative burst fails to exhaust the HSC pool, which rapidly returns to quiescence in response to chronic IFN-1 exposure. Moreover, we demonstrate that IFN-1–exposed HSCs with reestablished quiescence are largely protected from the killing effects of IFNs unless forced back into the cell cycle due to culture, transplantation, or myeloablative treatment, at which point they activate a p53-dependent proapoptotic gene program. Collectively, our results demonstrate that quiescence acts as a safeguard mechanism to ensure survival of the HSC pool during chronic IFN-1 exposure. We show that IFN-1s can poise HSCs for apoptosis but induce direct cell killing only upon active proliferation, thereby establishing a mechanism for the suppressive effects of IFN-1s on HSC function.Keywords
This publication has 43 references indexed in Scilit:
- Resilient and resourceful: Genome maintenance strategies in hematopoietic stem cellsExperimental Hematology, 2013
- GATA-3 regulates the self-renewal of long-term hematopoietic stem cellsNature Immunology, 2013
- Successes and Failures of Stem Cell Transplantation in Autoimmune DiseasesHematology, 2011
- The renaissance of interferon therapy for the treatment of myeloid malignanciesBlood, 2011
- Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and MutagenesisCell Stem Cell, 2010
- Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and RepairCell, 2008
- p38 MAP Kinase Regulates Stem Cell Apoptosis in Human Hematopoietic FailureCell Cycle, 2007
- Mechanisms of type-I- and type-II-interferon-mediated signallingNature Reviews Immunology, 2005
- Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defenceNature, 2003
- Suppression of Ovarian Follicle Activation in Mice by the Transcription Factor Foxo3aScience, 2003